Related Experiment Video
Updated: Jul 16, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Conformational diseases and structure-toxicity relationships: lessons from prion-derived peptides
Luisa Ronga1, Pasquale Palladino, Susan Costantini
1Dipartimento delle Scienze Biologiche, C.I.R.Pe.B., Università Federico II di Napoli, Istituto di Biostrutture e Bioimmagini, CNR, Via Mezzocannone 16, 80134 Napoli, Italy.
Prion diseases involve a normal protein misfolding into a toxic, aggregated form. Understanding prion protein structure is key to deciphering neurodegeneration and developing treatments.
Area of Science:
- Neuroscience
- Biochemistry
- Structural Biology
Background:
- The physiological prion protein (PrP) is conserved in mammals, essential for neuronal integrity, possibly involved in copper metabolism and oxidative stress response.
- Prion diseases are characterized by the conversion of normal PrP to an abnormal, insoluble, protease-resistant scrapie form.
- This conversion involves a significant conformational change from alpha-helical to beta-sheet secondary structures, leading to aggregation and neurotoxicity.
Purpose of the Study:
- To review the structural and functional aspects of prion protein.
- To elucidate the molecular basis of prion-induced conformational diseases.
- To analyze structure-activity relationships using prion fragments.
Main Methods:
- Review of existing literature on prion protein structure and function.
- Analysis of conformational changes (alpha-helical to beta-sheet).
- Focus on peptide fragments from N-terminal and C-terminal domains.
Main Results:
- The scrapie form of prion protein aggregates into amyloid fibrils in the central nervous system.
- Pathogenesis and molecular basis of nerve cell loss in prion diseases remain unclear.
- Structure-activity studies using prion fragments provide insights but can be complex to interpret.
Conclusions:
- Understanding the structural basis of prion protein aggregation is crucial for understanding prion diseases.
- Further research is needed to clarify the pathogenesis and toxicity mechanisms.
- Peptide-derived studies offer valuable, albeit complex, information on prion protein structure-activity relationships.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Folding
Protein Folding
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme can...

